Malignant otitis externa (MOE) is a life threatening pathology that may affect the external ear and skull base. Despite the nomenclature it is an infective disease process caused by Pseudomonas aeruginosa in up to 98 percent of cases (1). However when appropriate antibiotics fail, other infective organisms such as Aspergillus fumigatus should be considered, especially in the immunecompromised patient.
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CASE REPORT
A 63-year-old diabetic woman with recurrent glioblastoma multiformeYstatus after previous resection and adjuvant chemoradiation underwent a second craniotomy for resection of recurrent disease. Treatment also included several months of high-dose corticosteroid therapy (dexamethasone). The postoperative course was complicated by a pulmonary embolus requiring reintubation and purulent left otorrhea that did not respond to treatment with ciprofloxacin otic drops. On examination, the patient was obtunded and afebrile. Left ear examination revealed a normal pinna and postauricular skin but thickening and edema of the external auditory canal with obvious granulation tissue. The tympanic membrane was ruptured, and there was purulent otorrhea. The right ear examination was normal. Facial nerve examination demonstrated left facial weakness that was present preoperatively. The patient's white cell count was 9.3, and a previous swab culture of the left otorrhea grew A. fumigatus. A computed tomographic scan was obtained, which demonstrated mastoiditis and petrositis with erosion of bony septations, concerning for coalescent mastoiditis (Fig. 1) .
The patient was taken to the operating room for a left mastoidectomy. Intraoperative findings demonstrated soft, caseous bone in the mastoid cavity that did not bleed. Minimal purulence was encountered, and extensive granulation tissue was noted in the external auditory canal. Curettage specimens of the mastoid bone demonstrated numerous invasive spores and hyphae, displaying acute angle branching consistent with invasive A. fumigatus with multiple sites of bony invasion (Fig. 2, A and B) .
DISCUSSION
Malignant Otitis Externa or skull base osteomyelitis is a rare and potentially fatal infective process caused by P. aeruginosa in up to 98% of cases (1) . Other infective pathogens such as Staphylococcus aureus, Staphylococcus epidermidis, and A. fumigatus have also been reported.
Malignant otitis externa typically occurs in elderly diabetics or other immunocompromised individuals and typically presents with severe pain, otorrhea, spiking fevers, and granulation tissue in the external auditory canal (2) . Cranial nerve neuropathies are also seen, typically due to local invasion, with particular involvement of the facial nerve. Although facial nerve involvement is a sign of disease progression, it does not by itself worsen the prognosis (3) .
The clinical picture of fungal MOE is similar to that of bacterial, and as a result, the diagnosis of fungal disease is often delayed (1) . The most common fungal organism is A. fumigatus. Suspicion of fungal MOE should be raised particularly in individuals who initially do well on antimicrobial therapy but subsequently experience recrudescence or individuals who are unresponsive to appropriate antimicrobial therapy (4).
CONCLUSION
When managing otorrhea in diabetic patients or immunocompromised individuals, MOE should always be included in the differential diagnosis. Fungal cause should also be considered in individuals who are refractive to conventional antibiotic treatment or are extensively immunocompromised.
